Study of MHB088C for Patients With Advanced Solid Malignant Tumors

Clinical trial NCT07102004 · RECRUITING

Trial details

NCT number: NCT07102004
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced/Metastatic Solid Tumors

Start date: 2023-06-20
Primary completion: 2026-07-01
Enrollment: 515

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.